Sign in to continue:

Wednesday, April 8th, 2026

CDW Holding Limited Announces Differences Between Unaudited and Audited FY2025 Financial Results; No Dividend Details Disclosed

CDW Holding Limited: Analysis of Adjustments Between Unaudited and Audited FY2025 Financial Statements

CDW Holding Limited recently released a disclosure detailing material differences between its unaudited and audited financial statements for the fiscal year ended 31 December 2025. Investors should take note of these adjustments, as they affect both the Group’s equity and cash flow statements, with implications for the company’s overall financial health and transparency.

Key Financial Adjustments

Metric Unaudited (US\$’000) Audited (US\$’000) Variance (US\$’000) Explanation
Fair value adjustment reserve (1,172) (349) +823 Reclassification of cumulative fair value loss for unlisted equity investment in ELECTRINE INC. to retained earnings after fair value assessed as nil.
Retained earnings 20,835 20,018 -817 Matching reclassification from fair value adjustment reserve.
Retirement benefit obligation (Operating activities) (472) 51 +523 Reflects lower retirement benefit obligations due to director retirements in Japan subsidiary and auditors’ advice to separate payments and provision.
Retirement benefit obligation (Working capital change) (504) -504 New presentation of retirement benefit payments as per audit requirements.

Analysis of Adjustments and Exceptional Items

  • Fair Value Loss Realization: The most significant adjustment was related to a revaluation of an unlisted equity investment (ELECTRINE INC.), where the fair value was written down to nil. The loss, previously parked in the fair value adjustment reserve, has now been reclassified to retained earnings, reflecting its permanent impairment.
  • Retirement Benefit Obligations: The Group’s Japan subsidiary saw director retirements, resulting in a reduction in retirement benefit obligations. The auditors required payments and new provisions to be presented separately in the cash flow statement, yielding a more transparent view of cash movements related to these obligations.

Errors and Inconsistencies

  • Financial Statement Reclassification: The company’s need to make post-announcement adjustments and reclassifications—particularly for investments and retirement benefits—signals that material items were not fully accounted for in the unaudited results. While this reflects responsiveness to audit findings, it also highlights the importance of scrutinizing unaudited figures.

No Disclosure of Other Topics

  • There were no disclosures of dividends, historical performance trends, directors’ remuneration, corporate actions, or macro events in the provided document.

Conclusion and Recommendations

Overall, the adjustments do not indicate a fundamental deterioration in the underlying business but do highlight the risks attached to unlisted equity investments and the importance of robust accounting for employee benefits. The company’s willingness to adopt auditor recommendations and clarify its financials is a positive from a transparency standpoint.

  • If you currently hold CDW Holding Limited stock: Maintain a cautious but neutral stance. The adjustments are not alarming, but investors should monitor future disclosures for further asset impairments or unusual accounting adjustments. If your investment thesis is based on operational performance rather than investment gains, the core business appears relatively stable based on the limited data provided.
  • If you do not currently hold the stock: Consider waiting for the next set of full-year or interim financials before taking a position. The asset write-down and post-audit adjustments show the company is not immune to one-off shocks from non-core holdings. Further clarity on operating performance and dividend policy would be beneficial for potential new investors.

Disclaimer: This analysis is based solely on the company’s published differences between unaudited and audited FY2025 financial statements. It does not constitute investment advice. Investors should consider their own investment objectives, consult a financial adviser, and review future disclosures before making any investment decision.

View CDW Historical chart here



Hyphens Pharma Defies Economic Headwinds: 22% Revenue Surge Despite Q3 Profit Dip

Hyphens Pharma Reports Solid Q3 and 9M Performance Amid High...

   Ad